Cerebrospinal fluid asparagine depletion during pegylated asparaginase therapy in children with acute lymphoblastic leukaemia. (5th April 2014)

• Record Type: Journal Article
• Authors: Henriksen, Louise T.; Nersting, Jacob; Raja, Raheel A.; Frandsen, Thomas L.; Rosthøj, Steen; Schrøder, Henrik; Albertsen, Birgitte K.
• Is Part Of: British journal of haematology. Volume 166:Number 2(2014:Jul.)
• Page Start: 213
• Page End: 220
• Publication Date: 2014-04-05
• Subjects: acute lymphoblastic leukaemia -- pegylated asparaginase -- cerebrospinal fluid -- asparagine -- central nervous system; Hematology -- Periodicals; Blood -- Diseases -- Periodicals; 616.15
• DOI: 10.1111/bjh.12865
• Languages: English
• ISSNs: 0007-1048

Abstract

Summary: L‐asparaginase is an important drug in the treatment of childhood acute lymphoblastic leukaemia (ALL). Cerebrospinal fluid (CSF) asparagine depletion is considered a marker of asparaginase effect in the central nervous system (CNS) and may play a role in CNS‐directed anti‐leukaemia therapy. The objective of this study was to describe CSF asparagine depletion during 30 weeks of pegylated asparaginase therapy, 1000 iu/m 2 i.m. every second week, and to correlate CSF asparagine concentration with serum L‐asparaginase enzyme activity. Danish children (1–17 years) with ALL, treated according to the Nordic Society of Paediatric Haematology and Oncology ALL2008 protocol, standard and intermediate risk, were included. CSF samples were obtained throughout L‐asparaginase treatment at every scheduled lumbar puncture. A total of 128 samples from 31 patients were available for analysis. Median CSF asparagine concentration decreased from a pre‐treatment level of 5·3 μmol/l to median levels ≤1·5 μmol/l. However, only 4/31 patients (five samples) had CSF asparagine concentrations below the limit of detection (0·1 μmol/l). In 11 patients, 24 paired same day serum and CSF samples were obtained. A decrease in CSF asparagine corresponded to serum enzyme activities above 50 iu/l. Higher serum enzyme activities were not followed by more extensive depletion. In conclusion, pegylated asparaginase 1000 iu/m 2 i.m. every second week effectively reduced CSF asparagine levels.